We found that reduced or enhanced interferon responses in these human lung cancer cells altered viral entry and viral gene expression due to genetic deletions of IFN genes or high copy number of these genes and of other genes involved in IFN response, respectively. The gene discussed is IFNA1; the disease is lung carcinoma.